All Topic Areas
1 - 10 of 67 more >>
- Opioid intoxication
- Infantile-onset ascending hereditary spastic paralysis
- IAHSP
- spastic paralysis, infantile onset ascending
- Alzheimer disease, type 2
- Late Onset Alzheimer Disease
- Late-Onset Familial Alzheimer Disease (AD2)
- Senile Dementia
- Biotinidase deficiency
- Carboxylase Deficiency, Multiple, Late-Onset
Articles
1 - 5 of 6 more >>
- Childhood-Onset Schizophrenia: An Update from the NIMH
A child's stage of development must be taken into account when considering a diagnosis of mental illness.1 Behaviors that are normal at one age may not be at another. Rarely, a healthy young child may report strange experiences—such as hearing voices—that would be considered abnormal at a later age. Clinicians look for a more persistent pattern of such behaviors. Parents may have reason for concern if a child of 7 years or older often hears voices saying derogatory things about him or her,...
National Institute of Mental Health
- Infantile-onset ascending hereditary spastic paralysis
Infantile-onset ascending hereditary spastic paralysis is a rare disorder characterized by the progressive weakness and stiffness of arm, leg, and facial muscles. Symptoms of infantile-onset ascending hereditary spastic paralysis begin during infancy or early childhood and slowly worsen. The disorder begins with stiffness and weakness of the legs within the first 2 years of life. Patients are usually wheelchair-bound by late childhood or early adolescence. Weakness and stiffness of arm muscles...
Genetics Home Reference
- Rapid Gastric Emptying
Rapid gastric emptying, or dumping syndrome, happens when the lower end of the small intestine (jejunum) fills too quickly with undigested food from the stomach. "Early" dumping begins during or right after a meal. Symptoms of early dumping include nausea, vomiting, bloating, diarrhea, and shortness of breath. "Late" dumping happens 1 to 3 hours after eating. Symptoms of late dumping include weakness, sweating, and dizziness. Many people have both types. Certain types of...
National Institute of Diabetes and Digestive and Kidney Diseases
- FDA Clears Rapid Test for Aspergillus Infection
The Food and Drug Administration (FDA) today cleared for marketing the first rapid laboratory test for a life-threatening invasive fungal infection that occurs in leukemia patients, organ and bone marrow transplant patients, and patients whose immune systems are compromised by illness or chemotherapy. The test will allow doctors to diagnose invasive aspergillus infection quicker and begin treatment with anti-fungal drugs sooner. The new test, the Platelia Aspergillus EIA, manufactured by...
U.S. Food and Drug Administration
- FDA Introduces New Technology to Improve Food Security:
Electronic Food Facility Registration Goes "Live,"
Allowing More Than 400,000 Facilities to Register in
Minutes; FDA Reports on Progress in Developing
Rapid Tests of Food Contamination
The Food and Drug Administration today announced further steps to use modern technology to provide new protections for America’s food supply. First, FDA announced that its new electronic registration system for food facilities, foreign and domestic, will be “live” today at 6 p.m. Eastern Daylight Time. This registration system, available online at http://www.cfsan.fda.gov/~furls/ovffreg.html and designed to bolster the safety and security of America's food supply, will help...
U.S. Food and Drug Administration
News
1 - 5 of 686 more >>
- Opioid Prescribing At Forefront Of Pain Medicine Meeting
MedicalNewsToday - Sun, 11 Feb 2007 09:00 EST
- Child obesity linked to early puberty
The Earth Times - Mon, 05 Mar 2007 08:15 EST
- Wyeth And Progenics To Begin Clinical Testing Of A New Formulation Of Oral Methylnaltrexone Based On Phase 2 Findings
MedicalNewsToday - Wed, 07 Mar 2007 08:00 EST
- Single Genetic Defect Causes Early Heart Disease
MedicalNewsToday - Wed, 07 Mar 2007 09:00 EST
- Michael J. Fox Foundation Award Allows Exploration Of New Avenue In Parkinson's Therapy Development
MedicalNewsToday - Tue, 06 Mar 2007 05:00 EST
Clinical Trials
1 - 5 of 476 more >>
- Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20
ClinicalTrials.gov Identifier: NCT00000238 - Active, not recruiting
Opioid-Related Disorders
- Opioid Withdrawal Suppression with Tramadol - 1
ClinicalTrials.gov Identifier: NCT00142896 - Active, not recruiting
Opioid Dependence
- Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1
ClinicalTrials.gov Identifier: NCT00078130 - Active, not recruiting
Opioid-Related Disorders
- Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers - 3
ClinicalTrials.gov Identifier: NCT00134875 - Active, not recruiting
Opioid-Related Disorders
- Assessment of Tramadol as a Treatment for Opioid Addiction
ClinicalTrials.gov Identifier: NCT00301210 - Recruiting
Opioid-Related Disorders

Not Signed In -

